Literature DB >> 16644779

Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.

Chris Jones1, Paul Roderick, Scott Harris, Mary Rogerson.   

Abstract

BACKGROUND: The burden of chronic kidney disease (CKD) is high, but its natural history and the benefit of routine nephrology care is unclear. This study investigated the decline in kidney function prior to and following nephrology referral and its association with mortality.
METHODS: This study provides a retrospective review of the individual rates of glomerular filtration rate (GFR) decline (millilitre per minute per 1.73 m(2)/year) for the 5 years before and after referral in 726 new referrals with stages 3-5 CKD to one renal unit between 1997 and 2003. Blood pressures are averages at referral, 1 and 3 years post referral. Logistic regression and Cox's models tested factors predicting post-referral GFR decline and the impact on mortality.
RESULTS: Mean (SD) age was 72 (14), and 389 (54%) patients had stages 4-5 CKD. GFR decline slowed significantly from -5.4 ml/min/1.73 m(2)/year (-13. to -2) before to -0.35 ml/min/1.73 m(2)/year (-3 to +3) after referral (P < 0.001). Blood pressure also reduced significantly (155/84 to 149/80, P < 0.05) with most changes occurring within 1 year of referral. Factors predicting a non-progressive post-referral decline included a lower systolic blood pressure at referral and 1 year after referral, a CKD diagnosis other than diabetic nephropathy, less baseline proteinuria and a non-progressive pre-referral GFR decline. A non-progressive post-referral GFR decline was independently associated with significantly better survival (hazard ratio 0.55, 95% CI 0.40-0.75, P <or = 0.001) after adjustment for known risk factors.
CONCLUSIONS: Following nephrology referral, GFR decline slowed significantly and was associated with better survival. Earlier detection of patients with progressive CKD and interventions to slow progression may have benefits on both kidney and patient survival.

Entities:  

Mesh:

Year:  2006        PMID: 16644779     DOI: 10.1093/ndt/gfl198

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  65 in total

Review 1.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

2.  Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors?

Authors:  Ryo Kido; Yugo Shibagaki; Kazuhiro Iwadoh; Ichiro Nakajima; Shohei Fuchinoue; Toshiro Fujita; Satoshi Teraoka
Journal:  Clin Exp Nephrol       Date:  2010-03-26       Impact factor: 2.801

3.  Applying the Temporal Abstraction Technique to the Prediction of Chronic Kidney Disease Progression.

Authors:  Li-Chen Cheng; Ya-Han Hu; Shr-Han Chiou
Journal:  J Med Syst       Date:  2017-04-11       Impact factor: 4.460

4.  Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.

Authors:  Ai-Hua Zhang; Paul Tam; Denise LeBlanc; Hui Zhong; Christopher T Chan; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2009-07-04       Impact factor: 2.370

5.  Management of Diabetic Nephropathy in the Elderly: Special Considerations.

Authors:  Emaad M Abdel-Rahman; Tarek Alhamad; W Brian Reeves; Alaa S Awad
Journal:  J Nephrol Ther       Date:  2012-10

6.  Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.

Authors:  Robert B Hopkins; Amit X Garg; Adeera Levin; Anita Molzahn; Claudio Rigatto; Joel Singer; George Soltys; Steven Soroka; Patrick S Parfrey; Brendan J Barrett; Ron Goeree
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

Review 7.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

8.  eGFR: is it ready for early identification of CKD?

Authors:  Michal L Melamed; Carolyn Bauer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

9.  The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD.

Authors:  Guofen Yan; Alfred K Cheung; Jennie Z Ma; Alison J Yu; Tom Greene; M Norman Oliver; Wei Yu; Keith C Norris
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 8.237

10.  Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic.

Authors:  Hulya Taskapan; Paul Tam; Victoria Au; Stephen Chow; Jason Fung; Gordon Nagai; Janet Roscoe; Paul Ng; Tabo Sikaneta; Robert Ting; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.